Author

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Author Report for: Marcinkeviciene J

No contact information in database for Marcinkeviciene J




    Title: Substituted piperidinyl glycinyl 2-cyano-4,5-methano pyrrolidines as potent and stable dipeptidyl peptidase IV inhibitors
    Zhao G, Kwon C, Wang A, Robertson JG, Marcinkeviciene J, Parker RA, Kirby MS, Hamann LG
    Ref: Bioorganic & Medicinal Chemistry Lett, 23:1622, 2013 : PubMed

            

    Title: Potency, selectivity and prolonged binding of saxagliptin to DPP4: maintenance of DPP4 inhibition by saxagliptin in vitro and ex vivo when compared to a rapidly-dissociating DPP4 inhibitor
    Wang A, Dorso C, Kopcho L, Locke G, Langish R, Harstad E, Shipkova P, Marcinkeviciene J, Hamann L, Kirby MS
    Ref: BMC Pharmacol, 12:2, 2012 : PubMed

            

    Title: Discovery of 6-(Aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxa mides as Potent, Selective Dipeptidyl Peptidase-4 (DPP4) Inhibitors
    Meng W, Brigance RP, Chao HJ, Fura A, Harrity T, Marcinkeviciene J, O'Connor SP, Tamura JK, Xie D and Hamann LG <8 more author(s)>
    Ref: Journal of Medicinal Chemistry, 53:5620, 2010 : PubMed

            

    Title: Involvement of DPP-IV catalytic residues in enzyme-saxagliptin complex formation
    Metzler WJ, Yanchunas J, Weigelt C, Kish K, Klei HE, Xie D, Zhang Y, Corbett M, Tamura JK and Marcinkeviciene J <3 more author(s)>
    Ref: Protein Science, 17:240, 2008 : PubMed

            

    Title: Potent non-nitrile dipeptidic dipeptidyl peptidase IV inhibitors
    Simpkins LM, Bolton S, Pi Z, Sutton JC, Kwon C, Zhao G, Magnin DR, Augeri DJ, Gungor T and Hamann LG <12 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 17:6476, 2007 : PubMed

            

    Title: Seco-prolinenitrile inhibitors of dipeptidyl peptidase IV define minimal pharmacophore requirements at P1
    Magnin DR, Taunk PC, Robertson JG, Wang A, Marcinkeviciene J, Kirby MS, Hamann LG
    Ref: Bioorganic & Medicinal Chemistry Lett, 16:1731, 2006 : PubMed

            

    Title: Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Augeri DJ, Robl JA, Betebenner DA, Magnin DR, Khanna A, Robertson JG, Wang A, Simpkins LM, Taunk P and Hamann LG <14 more author(s)>
    Ref: Journal of Medicinal Chemistry, 48:5025, 2005 : PubMed

            

    Title: Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach
    Kopcho LM, Kim YB, Wang A, Liu MA, Kirby MS, Marcinkeviciene J
    Ref: Archives of Biochemistry & Biophysics, 436:367, 2005 : PubMed

            

    Title: Diprolyl nitriles as potent dipeptidyl peptidase IV inhibitors
    Zhao G, Taunk PC, Magnin DR, Simpkins LM, Robl JA, Wang A, Robertson JG, Marcinkeviciene J, Sitkoff DF and Hamann LG <2 more author(s)>
    Ref: Bioorganic & Medicinal Chemistry Lett, 15:3992, 2005 : PubMed

            


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer